The primary aim of R&D activity at Fluart is to meet and even overachieve the registration criteria of influenza vaccines to ensure the best possible quality to protect human lives against disease.

Besides the continuous flu related R&D Fluart is involved in several innovative areas of different vaccine developments, both of manufacturing and administration aspects, as well as in addressing diverse viral and bacterial challenging pathogens.